V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160012081 | 160005771 | 1.8 | 68 | null | 2018-03-31 | 2018-04-11 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100406258 |
| 160012082 | 160005772 | 1.75 | 59 | Palliative (P) | 2018-07-20 | 2018-07-26 | Liposomal Doxorubicin (Caelyx) | 02 | N | STS NON-RHABDO EPSSG 2005 IVA | 100670599 |
| 160012085 | 160005773 | 1.67 | 64.8 | Palliative (P) | 2018-02-20 | 2018-02-25 | Cisplatin + Etoposide (3 day) | null | N | DOXORUBICIN + IFOSFAMIDE | 100518648 |
| 160012089 | 160005774 | 1.75 | 72.8 | Palliative (P) | 2018-10-22 | 2018-10-22 | Paclitaxel 7 day | 02 | N | LIPOSOMAL DOXORUBICIN | 101766064 |
| 160012091 | 160005775 | 0 | 82 | Palliative (P) | 2020-06-01 | 2020-06-17 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100166901 |
| 160012098 | 160005777 | 1.87 | 69.6 | 03 | 2017-12-01 | 2017-12-01 | ETOP 13-18 BEAT-meso Trial | N | N | LIPOSOMAL DOXORUBICIN | 100434021 |
| 160012100 | 160005778 | 1.73 | 80.7 | Curative (C) | 2018-03-05 | 2018-03-11 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100247919 |
| 160012103 | 160005779 | 1.61 | null | Neo-adjuvant (N) | null | 2018-05-25 | Liposomal Doxorubicin (Caelyx) | 02 | N | CISPLATIN + ETOPOSIDE | 100129712 |
| 160012104 | 160005780 | 0 | 73.2 | Neo-adjuvant (N) | 2017-06-02 | 2017-06-27 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101420529 |
| 160012105 | 160005781 | 1.7 | 73 | null | 2016-08-09 | 2016-08-10 | EW EuroEwing 2012 Arm B VDC | 02 | N | DOXORUBICIN | 101560697 |
| 160012106 | 160005782 | 1.83 | 67.1 | Palliative (P) | 2020-01-01 | 2020-01-05 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100274103 |
| 160012107 | 160005783 | 1.8 | 71.65 | 03 | 2020-04-16 | 2020-04-20 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100033904 |
| 160012108 | 160005784 | null | 75.1 | Palliative (P) | null | 2018-10-28 | Paclitaxel 7 day | 02 | null | EURO-EWING | 100338198 |
| 160012109 | 160005785 | 1.79 | 7.8 | Curative (C) | null | 2018-07-13 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 100859972 |
| 160012110 | 160005786 | 1.85 | 65 | Palliative (P) | 2017-12-08 | 2017-12-15 | Doxorubicin 75mg/m2 | 02 | N | PEMBROLIZUMAB | 101868351 |
| 160012113 | 160005787 | 1.61 | 95 | null | 2017-10-02 | 2017-10-06 | IVADo | 02 | null | PEMETREXED | 100386817 |
| 160012114 | 160005788 | 1.8 | 48.5 | Palliative (P) | 2016-11-01 | 2016-11-01 | Cisplatin + Pemetrexed | 2 | N | CISPLATIN + PEMETREXED | 101207306 |
| 160012116 | 160005789 | 1.6 | 59.4 | Palliative (P) | 2018-09-02 | 2018-09-02 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100058775 |
| 160012117 | 160005790 | 1.58 | 67.7 | Palliative (P) | null | 2017-12-01 | null | 02 | N | CAPECITABINE | 100163942 |
| 160012127 | 160005792 | 1.78 | 93.2 | Palliative (P) | 2019-08-18 | 2019-08-21 | EW EuroEwing 2012 Arm B VDC | null | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100571727 |
| 160012128 | 160005793 | null | 47 | Neo-adjuvant (N) | 2017-09-08 | 2017-09-10 | VIDE | 02 | N | NOT MATCHED | 100878492 |
| 160012129 | 160005794 | 1.74 | 101 | Curative (C) | 2018-04-10 | 2018-04-21 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100279945 |
| 160012130 | 160005795 | 1.78 | 84.1 | Palliative (P) | 2021-12-04 | 2021-12-04 | Carboplatin + Liposomal Doxorubicin | 02 | N | CISPLATIN | 100628475 |
| 160012131 | 160005796 | 1.63 | 104.6 | Palliative (P) | 2019-11-02 | 2019-11-22 | DOXORUBICIN | N | N | EURO-EWING | 100394802 |
| 160012133 | 160005797 | 1.59 | 75.65 | Palliative (P) | 2017-03-09 | 2017-03-11 | DOXORUBICIN | 2 | N | TRIAL UNSPECIFIED | 101269522 |
| 160012136 | 160005798 | 1.89 | 68.5 | Palliative (P) | 2019-04-17 | 2019-04-19 | Doxorubicin + Olaratumab | 02 | Y | IDARUBICIN | 101810958 |
| 160012138 | 160005799 | 1.65 | 71.6 | Palliative (P) | 2020-02-10 | 2020-02-11 | MELPHALAN | 01 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100289178 |
| 160012141 | 160005800 | 1.63 | 90.3 | Palliative (P) | 2016-01-22 | 2016-02-16 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | TRIAL | 100677858 |
| 160012142 | 160005801 | 1.14 | 80 | Palliative (P) | 2019-12-30 | 2020-01-04 | Cisplatin + Pemetrexed | 02 | N | TRIAL UNSPECIFIED | 100754439 |
| 160012145 | 160005802 | 1.73 | 84.8 | null | 2016-09-17 | 2016-10-01 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101133406 |
| 160012146 | 160005803 | 1.62 | 69.5 | Palliative (P) | 2017-08-26 | 2017-09-20 | Trial Unspecified | 02 | N | CARBOPLATIN + PACLITAXEL | 100072308 |
| 160012147 | 160005804 | 1.62 | 74.1 | null | 2017-12-29 | 2017-12-29 | Trial Unspecified | 02 | null | DOXORUBICIN | 100091205 |
| 160012152 | 160005805 | 1.85 | 73.5 | Palliative (P) | 2017-06-12 | 2017-07-17 | Docetaxel 75mg/m2 (21 day) | 02 | N | LIPOSOMAL DOXORUBICIN | 100826123 |
| 160012153 | 160005806 | 1.82 | 86.2 | 03 | null | 2017-11-11 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100603299 |
| 160012160 | 160005807 | null | null | null | 2018-04-05 | 2018-04-07 | DOXORUBICIN | 02 | null | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 100926246 |
| 160012167 | 160005808 | 1.62 | 83.7 | Curative (C) | 2016-12-27 | 2017-01-04 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | BUSULPHAN | 100619047 |
| 160012170 | 160005809 | 1.63 | 60.55 | Palliative (P) | 2016-09-09 | 2016-09-09 | Trial Unspecified | 02 | N | IMATINIB | 100055322 |
| 160012172 | 160005810 | 0.84 | 88 | Disease modification (D) | 2017-07-23 | 2017-08-14 | Carboplatin + Paclitaxel (weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101340735 |
| 160012173 | 160005811 | 1.59 | 54.2 | null | 2018-11-28 | 2018-11-28 | Doxorubicin + Olaratumab | N | N | CYCLOPHOSPHAMIDE | 100726938 |
| 160012176 | 160005812 | 1.71 | 92.7 | Palliative (P) | 2017-05-30 | 2017-05-31 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100335715 |
| 160012177 | 160005813 | 1.51 | 73.4 | Palliative (P) | 2016-06-26 | 2016-07-05 | Carboplatin + Paclitaxel (3 weekly) | null | N | CARBOPLATIN + PACLITAXEL | 100569435 |
| 160012178 | 160005814 | 1.72 | 91 | Neo-adjuvant (N) | 2017-11-02 | 2017-11-02 | GEMCARBO | 02 | N | LIPOSOMAL DOXORUBICIN | 101325010 |
| 160012179 | 160005815 | 1.75 | 79 | Palliative (P) | 2016-05-04 | 2016-05-05 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100543171 |
| 160012180 | 160005816 | 1.58 | 96.6 | Palliative (P) | 2018-08-05 | 2018-08-24 | Cisplatin + Pemetrexed | 02 | N | DOXORUBICIN | 100361780 |
| 160012181 | 160005817 | 1.7 | 6.6 | Neo-adjuvant (N) | 2019-10-31 | 2019-11-07 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 101429665 |
| 160012184 | 160005818 | 1.74 | 73 | Palliative (P) | 2016-01-20 | 2016-02-12 | Imatinib 400mg | N | N | TRIAL UNSPECIFIED | 100627626 |
| 160012188 | 160005820 | 1.83 | 69 | Palliative (P) | 2018-08-20 | 2018-08-25 | Liposomal Doxorubicin (Caelyx) | 02 | N | CVD (NEUROENDOCRINE) | 101643763 |
| 160012190 | 160005821 | 0 | 86.3 | Palliative (P) | 2019-01-16 | 2019-01-30 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | CAPECITABINE | 101542188 |
| 160012191 | 160005822 | 1.81 | 77 | Palliative (P) | 2018-05-01 | 2018-05-16 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100556232 |
| 160012192 | 160005823 | null | 58.7 | null | null | 2018-07-10 | Doxorubicin + Olaratumab | 01 | N | CARBOPLATIN + PACLITAXEL | 101171512 |